Possible scenario
Execution Risks Dominate
21% Chance
The market focuses on the difficulty of bringing complex medical-device production back to the US at scale. Higher labor costs, permitting delays, validation requirements, and FDA quality controls could delay the financial payoff.
Secondary impacts
- Healthcare -0.2%
- Industrials -0.1%
Tickers
- BDX-1.9%
- MDT-0.4%
- NB+0.2%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.